INTERNATIONAL PATENT: THERAVANCE BIOPHARMA R&D IP, LLC FILES APPLICATION FOR "TRIAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS"

GENEVA, Oct. 20 -- THERAVANCE BIOPHARMA R&D IP, LLC (901 Gateway BoulevardSouth San Francisco, California 94080) filed a patent application (PCT/US2025/024337) for "TRIAZOLO INDAZOLE COMPOUNDS AS JAK INHIBITORS" on Apr 11, 2025. With publication no. WO/2025/217560, the details related to the patent application was published on Oct 16, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MCKINNELL, Robert Murray (c/o Theravance Biopharma R&D IP, LLC901 Gateway BoulevardSouth San Francisco, California 94080), BORALSKY, Luke (c/o Theravance Biopharma R&D IP, LLC901 Gateway BoulevardSouth San Francis...